Halma plc (HLMA.L)
- Previous Close
2,200.00 - Open
2,191.00 - Bid --
- Ask --
- Day's Range
2,158.00 - 2,196.00 - 52 Week Range
1,802.00 - 2,520.95 - Volume
394,889 - Avg. Volume
811,948 - Market Cap (intraday)
8.246B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
34.65 - EPS (TTM)
0.63 - Earnings Date Jun 13, 2024
- Forward Dividend & Yield 0.21 (0.94%)
- Ex-Dividend Date Dec 21, 2023
- 1y Target Est
2,326.79
Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire safety, fire detection and fire suppression; safe movement in public, commercial, and industrial spaces; elevator safety; communications in emergencies; control of access in potentially hazardous industrial and commercial environments; electrical safety; and the safe management of pipelines and storage assets solutions. This segment serves shops and restaurants, healthcare facilities, and offices and stadiums; industrial and logistics assets; public spaces and critical infrastructure; and aerospace, and rail and automotive markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring, water and waste water analysis and treatment, gas analysis and detection, and optical analysis systems. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; components, devices and systems that provide information and analytics to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
www.halma.comRecent News: HLMA.L
Performance Overview: HLMA.L
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HLMA.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HLMA.L
Valuation Measures
Market Cap
8.31B
Enterprise Value
8.93B
Trailing P/E
35.02
Forward P/E
25.84
PEG Ratio (5yr expected)
4.30
Price/Sales (ttm)
4.33
Price/Book (mrq)
5.04
Enterprise Value/Revenue
4.63
Enterprise Value/EBITDA
21.13
Financial Highlights
Profitability and Income Statement
Profit Margin
12.35%
Return on Assets (ttm)
7.74%
Return on Equity (ttm)
14.52%
Revenue (ttm)
1.93B
Net Income Avi to Common (ttm)
238M
Diluted EPS (ttm)
0.63
Balance Sheet and Cash Flow
Total Cash (mrq)
136.4M
Total Debt/Equity (mrq)
45.76%
Levered Free Cash Flow (ttm)
243.65M